Medinol announces that it obtained CE-mark for EluNIR™, its novel Drug Eluting Stent and first post CE-mark patient implantations at San Raffaele Hospital in Milan, Italy. more
Medinol
News
News
-
-
Medinol Ltd. Receives CE Mark for the EluNIR™ Ridaforolimus-Eluting Coronary Stent System, and announces first commercial implantations
Medinol announces that it obtained CE-mark for EluNIR™, its novel Drug Eluting Stent and first post CE-mark patient implantations at San Raffaele Hospital in Milan, Italy. more
-
Medinol announces excellent clinical results for EluNIR, a novel Drug Eluting Stent
PARSIPPANY, N.J., Dec. 21, 2016, PRNewswire - Medinol announced excellent twelve month clinical results from the BIONICS study. The study was conducted to evaluate EluNIR™... more
-
Medinol announces excellent clinical results for EluNIR, a novel Drug Eluting Stent
PARSIPPANY, N.J., Dec. 21, 2016, PRNewswire - Medinol announced excellent twelve month clinical results from the BIONICS study. The study was conducted to evaluate EluNIR™... more
-
Medinol Receives Approval from The Japanese PMDA to Begin Clinical Study on Novel DES
PARSIPPANY, N.J. – Medinol announces the receipt of a Clinical Trial Notification from the PDMA in Japan to initiate its regulatory approval study for EluNIR™ stent system... more
-
Medinol Receives Approval from The Japanese PMDA to Begin Clinical Study on Novel DES
PARSIPPANY, N.J. – Medinol announces the receipt of a Clinical Trial Notification from the PDMA in Japan to initiate its regulatory approval study for EluNIR™ stent system... more
-
Study Finds Medinol’s Ridaforolimus-Eluting Stent Is Non-Inferior to Zotarolimus-Eluting Stent Based On One-Year Clinical Outcomes
WASHINGTON – October 30, 2016 – The large multinational randomized BIONICS study found that a novel ridaforolimus-eluting stent (BioNIR) was non-inferior to a zotarolimus-eluting stent... more
-
Study Finds Medinol’s Ridaforolimus-Eluting Stent Is Non-Inferior to Zotarolimus-Eluting Stent Based On One-Year Clinical Outcomes
WASHINGTON – October 30, 2016 – The large multinational randomized BIONICS study found that a novel ridaforolimus-eluting stent (BioNIR) was non-inferior to a zotarolimus-eluting stent... more